Answer
Yes, Tavlesse (fostamatinib) is contraindicated during pregnancy, and treatment should be discontinued if pregnancy occurs.
Sources for this answer
- Tavlesse 100 mg film-coated tabletsGrifols UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked